the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
mail this article
.
.
.
'indian ip and liabilities law barrier to pharma r&d investment'
.
photos
.
msnbc host chris hayes says that trump asked gates this twice: once at their meeting in 2017, and again at their meeting in 2018.
.